Published January 1998 | Version v1
Journal article

Amplatz Thrombectomy Device: Unexpected Interaction with the Cragg Endoprosthesis

  • 1. Klinik fuer Radiologische Diagnostik, Christian-Albrechts-Universitaet zu Kiel, Arnold-Heller-Strasse 9, D-24105 Kiel (Germany)

Description

In a 74-year-old woman, a Dacron-covered Cragg endoprosthesis was implanted into the left superficial femoral artery after successful recanalization of a 6-cm-long occlusion. At 4.5 months after discharge the endoprosthesis was occluded. In order to perform a thrombectomy, an Amplatz thrombectomy device (ATD) was activated and advanced into the occluded graft. Suddenly, a mechanical failure of the ATD occurred. Extraction of the ATD was achieved only after repeated attempts at rotating motion and jerky pullback maneuvers. The most likely explanation is that one of the graft-struts had advanced into the tip of the ATD and resulted in a broken drive shaft. Recanalization was completed by performing percutaneous transluminal angioplasty and pharmacological thrombolysis with recombinant human-tissue plasminogen activator. In conclusion, users of the ATD have to be aware of interactions of the ATD with the struts of implanted stents or grafts during thrombectomy

Additional details

Identifiers

Publishing Information

Journal Title
Cardiovascular and Interventional Radiology
Journal Volume
21
Journal Issue
1
Journal Page Range
p. 73-75
ISSN
0174-1551
CODEN
CAIRDG

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
39093118
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ANIMAL TISSUES; ARTERIES; DACRON; GRAFTS; PLASMINOGEN; VASCULAR DISEASES
Descriptors DEC
BLOOD COAGULATION FACTORS; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; DISEASES; DRUGS; ESTERS; FIBRINOLYTIC AGENTS; HEMATOLOGIC AGENTS; ORGANIC COMPOUNDS; ORGANIC POLYMERS; ORGANS; POLYESTERS; POLYMERS; PROTEINS; TRANSPLANTS

Optional Information

Copyright
Copyright (c) 1998 Springer-Verlag New York Inc.